These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19141387)

  • 1. The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
    Gratzinger D; Zhao S; West R; Rouse RV; Vogel H; Gil EC; Levy R; Lossos IS; Natkunam Y
    Am J Clin Pathol; 2009 Feb; 131(2):264-78. PubMed ID: 19141387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.
    Nakata K; Ohuchida K; Nagai E; Hayashi A; Miyasaka Y; Kayashima T; Yu J; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
    Neoplasia; 2009 Jul; 11(7):712-9. PubMed ID: 19568416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
    Yamada Y; Pannell R; Forster A; Rabbitts TH
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
    Natkunam Y; Zhao S; Mason DY; Chen J; Taidi B; Jones M; Hammer AS; Hamilton Dutoit S; Lossos IS; Levy R
    Blood; 2007 Feb; 109(4):1636-42. PubMed ID: 17038524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
    Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
    Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
    Folpe AL; Chand EM; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
    Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
    Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of LMO2 as a new marker for acinic cell carcinoma of salivary gland.
    Sheng D; Zhang Y; Xue T; Zhou XY; Li XQ
    Diagn Pathol; 2022 Jan; 17(1):15. PubMed ID: 35094691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene.
    Bégay-Müller V; Ansieau S; Leutz A
    FEBS Lett; 2002 Jun; 521(1-3):36-8. PubMed ID: 12067721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.
    Osada H; Grutz GG; Axelson H; Forster A; Rabbitts TH
    Leukemia; 1997 Apr; 11 Suppl 3():307-12. PubMed ID: 9209374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Bex2 interacts with LMO2 and regulates the transcriptional activity of a novel DNA-binding complex.
    Han C; Liu H; Liu J; Yin K; Xie Y; Shen X; Wang Y; Yuan J; Qiang B; Liu YJ; Peng X
    Nucleic Acids Res; 2005; 33(20):6555-65. PubMed ID: 16314316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β.
    Sun W; Shen W; Yang S; Hu F; Li H; Zhu TH
    Cell Res; 2010 Oct; 20(10):1158-69. PubMed ID: 20856265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.
    Sun W; Shen WW; Yang S; Hu F; Gao Y; Qiao YH; Zhu TH
    J Biomed Sci; 2010 Mar; 17(1):22. PubMed ID: 20346173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
    Yamada Y; Warren AJ; Dobson C; Forster A; Pannell R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3890-5. PubMed ID: 9520463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms.
    Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction.
    Lécuyer E; Larivière S; Sincennes MC; Haman A; Lahlil R; Todorova M; Tremblay M; Wilkes BC; Hoang T
    J Biol Chem; 2007 Nov; 282(46):33649-33658. PubMed ID: 17878155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression.
    Bianchi E; Zini R; Salati S; Tenedini E; Norfo R; Tagliafico E; Manfredini R; Ferrari S
    Blood; 2010 Nov; 116(22):e99-110. PubMed ID: 20686118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
    Appert A; Nam CH; Lobato N; Priego E; Miguel RN; Blundell T; Drynan L; Sewell H; Tanaka T; Rabbitts T
    Cancer Res; 2009 Jun; 69(11):4784-90. PubMed ID: 19487290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
    Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
    Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.